We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+28.74%
3 Year Est. Return
+89.7%
5 Year Est. Return
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$393M
Cap. Flow
+$218M
Cap. Flow %
9.84%
Top 10 Hldgs %
19.94%
Holding
4,413
New
404
Increased
2,760
Reduced
745
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 12.54%
2 Financials 7.15%
3 Consumer Discretionary 5.77%
4 Industrials 3.78%
5 Healthcare 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSHA icon
3901
Taysha Gene Therapies
TSHA
$1.78B
$473 ﹤0.01%
205
-167
-45% -$363
ERII icon
3902
Energy Recovery
ERII
$470M
$472 ﹤0.01%
37
-36
-49% -$488
MGTX icon
3903
MeiraGTx Holdings
MGTX
$1.14B
$469 ﹤0.01%
72
-131
-65% -$774
ALT icon
3904
Altimmune
ALT
$597M
$464 ﹤0.01%
+120
New +$649
GUTS icon
3905
Fractyl Health
GUTS
$109M
$462 ﹤0.01%
285
+80
+39% +$129
OGI
3906
Organigram Holdings
OGI
$140M
$455 ﹤0.01%
337
BDTX icon
3907
Black Diamond Therapeutics
BDTX
$102M
$454 ﹤0.01%
183
+117
+177% +$225
ULCC icon
3908
Frontier Group Holdings
ULCC
$1.84B
$450 ﹤0.01%
124
-93
-43% -$341
FDMT icon
3909
4D Molecular Therapeutics
FDMT
$536M
$449 ﹤0.01%
121
+117
+2,925% +$411
RAPT
3910
DELISTED
RAPT Therapeutics
RAPT
$448 ﹤0.01%
56
-35
-38% -$267
KYTX icon
3911
Kyverna Therapeutics
KYTX
$473M
$445 ﹤0.01%
145
-370
-72% -$915
CCCC icon
3912
C4 Therapeutics
CCCC
$399M
$444 ﹤0.01%
310
+277
+839% +$403
LWAY icon
3913
Lifeway Foods
LWAY
$449M
$444 ﹤0.01%
18
+14
+350% +$332
GCTS
3914
GCT Semiconductor Holding
GCTS
$203M
$444 ﹤0.01%
298
+227
+320% +$306
LFCR icon
3915
Lifecore Biomedical
LFCR
$163M
$438 ﹤0.01%
54
-11
-17% -$74
PLSE icon
3916
Pulse Biosciences
PLSE
$2.64B
$438 ﹤0.01%
29
+16
+123% +$265
CLFD icon
3917
Clearfield
CLFD
$459M
$434 ﹤0.01%
10
-1
-9% -$34
INSE icon
3918
Inspired Entertainment
INSE
$183M
$433 ﹤0.01%
53
+39
+279% +$302
BLZE icon
3919
Backblaze
BLZE
$1.19B
$429 ﹤0.01%
78
+50
+179% +$254
DHC
3920
Diversified Healthcare Trust
DHC
$2.13B
$429 ﹤0.01%
120
+80
+200% +$231
KITT icon
3921
Nauticus Robotics
KITT
$7.39M
$428 ﹤0.01%
+7
New +$494
CLNE icon
3922
Clean Energy Fuels
CLNE
$412M
$427 ﹤0.01%
219
+173
+376% +$294
IQ icon
3923
iQIYI
IQ
$1.28B
$427 ﹤0.01%
241
-17
-7% -$31
MDWD icon
3924
MediWound
MDWD
$184M
$426 ﹤0.01%
+22
New +$415
SCHC icon
3925
Schwab International Small-Cap Equity ETF
SCHC
$5.56B
$426 ﹤0.01%
+10
New +$387

Similar funds

EverSource Wealth Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, EverSource Wealth Advisors held 4,413 positions worth $2.21B, up 22% from $1.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EverSource Wealth Advisors deployed $218M of net new capital in Q2 2025, opening 404 new positions and adding to 2,760 existing holdings. Its largest new stake was Praxis Impact Large Cap Value ETF: 1,041,021 shares worth $29.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard International Dividend Appreciation ETF, an estimated $10.2M trimmed.

  • EverSource Wealth Advisors's largest Q2 2025 buy was Praxis Impact Large Cap Value ETF: 1,041,021 shares worth $29.5M.
  • EverSource Wealth Advisors added most to Vanguard 0-3 Month Treasury Bill ETF in Q2 2025, an estimated $9.75M increase.
  • EverSource Wealth Advisors's biggest Q2 2025 reduction was Vanguard International Dividend Appreciation ETF, cutting an estimated $10.2M.
  • EverSource Wealth Advisors fully exited State Street SPDR S&P Regional Banking ETF in Q2 2025, selling an estimated $2.75M.
  • EverSource Wealth Advisors's ten largest holdings make up 20% of its $2.21B portfolio in Q2 2025.
  • EverSource Wealth Advisors opened 404 new positions and closed 164 in Q2 2025.
  • EverSource Wealth Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.

Based on EverSource Wealth Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.